MedTrace Logo

Research on Community Based ATK Test Study to Control Spread of COVID-19 in Migrant Community

NCT05557513 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1310

Last updated 2024-04-11

No results posted yet for this study

Summary

Thousands of migrants from Myanmar have arrived in Thailand for their safety, better living standards and employment opportunities. They are often in Thailand illegally and have poor access to the Thai health care system. This underutilization not only puts their health at risk but may also put the general public's health at risk. During the COVID-19 pandemic, migrants often have no access to diagnostic tests even though global health actors are focused on accelerating access to COVID-19 testing. SARS-CoV-2 testing is one of the most effective and necessary means of mitigating the COVID-19 pandemic.

The overarching goal of this study is to provide evidence on effectiveness and feasibility of community-based SARS-CoV-2 antigen rapid diagnostic test (Ag-RDT) application in the Myanmar migrant community, Tak Province along the Thai Myanmar border as part of test-trace-isolation strategies to fight COVID-19.

After the study has been completed, the study team will have evidence to inform policymakers on whether community based SARS-CoV-2 Ag-RDT test-trace-isolate strategy is effective and feasible to fight COVID-19 where there is limited or no access to COVID-19 testing in the Myanmar migrant communities.

Conditions

  • COVID-19 Pandemic

Interventions

DEVICE

STANDARD Q COVID-19 Ag Test

Device Name: STANDARD Q COVID-19 Ag Test Manufactured by SD Biosensor, Inc., Korea Purpose: To detect COVID-19 (Its manufacture specification sensitivity was at 84.97% and specificity 98.4%)

Sponsors & Collaborators

  • University of Oxford

    lead OTHER

Principal Investigators

  • Dr Thaw Htwe MIn · Shoklo Malaria Research Unit (SMRU) 69/30 Ban Tung Road, Maesot63110, Tak, Thailand Tel: +66-087-307-0971

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-18
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05557513 on ClinicalTrials.gov